erythromycin has been researched along with quinupristin-dalfopristin in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (57.69) | 18.2507 |
2000's | 16 (30.77) | 29.6817 |
2010's | 5 (9.62) | 24.3611 |
2020's | 1 (1.92) | 2.80 |
Authors | Studies |
---|---|
Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Chin, NX; Gu, JW; Neu, HC | 1 |
Chrysos, G; Fraser, HY; Hardie, JM; Maskell, JP; Sefton, AM; Shain, H; Williams, JD | 1 |
Adam, D | 1 |
Chin, NX; Neu, HC | 1 |
Cohen, R; Fremaux, A; Geslin, P; Sissia, G | 1 |
Goto, S; Kaneko, Y; Miyazaki, S | 1 |
Brumfitt, W; Hamilton-Miller, JM; Shah, S | 1 |
Verbist, L; Verhaegen, J | 1 |
Inoue, K; Inoue, M; Mitsuhashi, S; Okamoto, R; Okubo, T | 1 |
Dubois, J; Joly, JR | 1 |
Drugeon, H; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
Entenza, JM; Glauser, MP; L'Hériteau, F; Lacassin, F; Leport, C; Moreillon, P | 1 |
Barry, AL; Fuchs, PC | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 2 |
Hof, H; Kretschmar, M; Nichterlein, T | 1 |
Appelbaum, PC; Jacobs, MR; Lichtenberger, C; Pankuch, GA | 1 |
Alcaide, F; Carratala, J; Gudiol, F; Liñares, J; Martin, R | 1 |
Biedenbach, D; Jones, RN; Wanger, A | 1 |
Houlihan, HH; Kaatz, GW; Mercier, RC; Rybak, MJ | 1 |
Iino, S; Iwasawa, H; Nakashio, S; Shimada, J | 1 |
Caron, F; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Wennersten, CB | 1 |
Maskell, JP; Sefton, AM; Whiley, AC; Williams, JD | 1 |
Jorgensen, JH; McElmeel, ML | 1 |
Arnold, B; Stout, JE; Yu, VL | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 2 |
Kresken, M; Lemperle, M; Lütticken, R; Mechery, V; Reinert, RR | 1 |
Betriu, C; Boloix, A; Culebras, E; Gómez, M; Palau, ML; Picazo, JJ; Redondo, M; Sánchez, A | 1 |
Auckenthaler, R; Courvalin, P; Féger, C; Roche, G | 1 |
Almaraz, F; Baquero, F; Cantón, R; Galán, JC; Loza, E; Morosini, MI; Negri, MC | 1 |
Cartwright, FD; Kenny, GE | 1 |
Bordi, E; D'Ambrosio, F; Del Grosso, M; Pantosti, A; Scotto D'Abusco, A | 1 |
Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
Abb, J | 1 |
Canales, M; Capilla, S; Cerdá Zolezzi, P; Durán, E; Gómez-Lus, R; Goñi, P; Millán, L; Rubio Calvo, MC | 1 |
Arslan, H; Azap, OK; Gagir, U; Oruç, E; Timurkaynak, F; Yapar, G | 1 |
Kilic, B; Kruse, M; Stahlmann, R | 1 |
D'Costa, VM; Hughes, DW; McGrann, KM; Wright, GD | 1 |
Adamkiewicz, T; Miller, ML; Montgomery, J; Obert, CA; Tuomanen, EI | 1 |
Flick, B; Kilic, B; Kruse, M; Stahlmann, R | 1 |
Bilewska, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Szymanek, K | 1 |
Choi, EC; Kim, H; Kwon, AR; Shim, MJ; Yoon, EJ; Yoon, JM | 1 |
Janata, J; Novotná, G; Spízek, J | 1 |
Aslam, M; Diarra, MS; Rempel, H; Service, C | 1 |
Avlami, A; Evangelopoulos, A; Hadjisoteriou, M; Petrikkos, G; Vallianou, N | 1 |
Beall, B; Chochua, S; Hawkins, PA; Jackson, D; McGee, L | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Chen, CJ; Chuang, YY; Huang, YC; Ko, WC; Lauderdale, TY; Lee, CY; Lu, CT; Lu, MC; Wu, TS; Yang, CC | 1 |
Min, YH; Park, B | 1 |
1 review(s) available for erythromycin and quinupristin-dalfopristin
Article | Year |
---|---|
Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Erythromycin; Humans; Infant; Virginiamycin | 1992 |
51 other study(ies) available for erythromycin and quinupristin-dalfopristin
Article | Year |
---|---|
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacteria, Anaerobic; Erythromycin; Microbial Sensitivity Tests; Mouth; Streptococcus; Virginiamycin | 1992 |
Post-antibiotic effect of the new streptogramin RP 59500.
Topics: Clindamycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Microbial Sensitivity Tests; Oxacillin; Staphylococcus; Streptococcus; Time Factors; Virginiamycin | 1992 |
In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
Topics: Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Streptococcus pneumoniae; Virginiamycin | 1992 |
The in-vitro activity of RP 59500 against gram-positive cocci.
Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Topics: Erythromycin; Gram-Positive Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Topics: Ampicillin; Cefotaxime; Erythromycin; Gram-Positive Cocci; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Virginiamycin | 1992 |
In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Legionella; Microbial Sensitivity Tests; Respiratory Tract Infections; Rifampin; Virginiamycin | 1992 |
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.
Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 1995 |
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.
Topics: Animals; Conjugation, Genetic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus; Vancomycin; Virginiamycin | 1995 |
In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens.
Topics: Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus; Virginiamycin | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
RP 59500, a streptogramin derivative, is effective in murine listeriosis.
Topics: Animals; Anti-Bacterial Agents; Erythromycin; In Vitro Techniques; Listeria monocytogenes; Mice; Microbial Sensitivity Tests; Virginiamycin | 1996 |
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Quinolones; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Penicillin Resistance; Streptococcal Infections; Streptococcus; Virginiamycin | 1996 |
Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Rifampin; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim; Virginiamycin | 1996 |
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Topics: Anti-Bacterial Agents; Blood Coagulation; Blood Platelets; Drug Administration Schedule; Drug Resistance, Microbial; Erythromycin; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Virginiamycin | 1997 |
[Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Enterococcus; Erythromycin; Gram-Positive Cocci; Humans; Methicillin Resistance; Roxithromycin; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Virginiamycin | 1997 |
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cell Cycle; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin | 1997 |
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
Topics: Amoxicillin; Anti-Bacterial Agents; Enterococcus; Erythromycin; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Virginiamycin | 1997 |
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Culture Media; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillins; Virginiamycin | 1997 |
Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Macrolides; Microbial Sensitivity Tests; Monocytes; Roxithromycin; Virginiamycin | 1998 |
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
Topics: Anti-Bacterial Agents; Clindamycin; Erythromycin; Humans; Ketolides; Macrolides; Penicillin Resistance; Phenotype; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 1998 |
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Kinetics; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Virginiamycin | 1998 |
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; North America; Staphylococcus; Streptococcus; Virginiamycin | 1998 |
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Streptococcus; Virginiamycin | 2000 |
In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Vancomycin Resistance; Virginiamycin | 2000 |
In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Spain; Streptococcus pneumoniae; Virginiamycin | 2001 |
Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities
Topics: 4-Quinolones; Acetamides; Aminoglycosides; Anti-Bacterial Agents; Aza Compounds; Erythromycin; Fluoroquinolones; Gatifloxacin; Humans; Hydrogen-Ion Concentration; Ketolides; Linezolid; Macrolides; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycoplasma hominis; Mycoplasma pneumoniae; Oxazolidinones; Quinolines; Tetracyclines; Tigecycline; Ureaplasma urealyticum; Virginiamycin | 2001 |
Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrophoresis, Agar Gel; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Polymerase Chain Reaction; Streptococcus pneumoniae; Virginiamycin | 2001 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Comparative activity of linezolid, quinupristin-dalfopristin and newer quinolones against Streptococcus pneumoniae.
Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythromycin; Humans; In Vitro Techniques; Linezolid; Oxazolidinones; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Virginiamycin | 2003 |
Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Ketolides; Lincosamides; Linezolid; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcaceae; Streptogramin B; Tetracycline Resistance; Virginiamycin; Viridans Streptococci | 2004 |
Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Turkey; Virginiamycin | 2005 |
The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926).
Topics: Anti-Bacterial Agents; Cell Adhesion Molecules; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Flow Cytometry; Humans; Levofloxacin; Ofloxacin; Phlebitis; Virginiamycin | 2006 |
Sampling the antibiotic resistome.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Soil Microbiology; Streptomyces; Trimethoprim Resistance; Vancomycin Resistance; Virginiamycin | 2006 |
Quinupristin-dalfopristin nonsusceptibility in pneumococci from sickle cell disease patients.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Phylogeny; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Virginiamycin | 2007 |
Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis.
Topics: Animals; Anti-Bacterial Agents; BALB 3T3 Cells; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Erythromycin; Fibroblasts; Humans; Infusions, Intravenous; Inhibitory Concentration 50; Levofloxacin; Mice; No-Observed-Adverse-Effect Level; Ofloxacin; Phlebitis; Reproducibility of Results; Toxicity Tests; Virginiamycin | 2007 |
[MIC and MBC of quinupristin/dalfopristin of erythromycin-resistant MRSA strains isolated from clinical specimens].
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Inhibitory Concentration 50; Methicillin Resistance; Microbial Sensitivity Tests; Species Specificity; Staphylococcus aureus; Virginiamycin | 2006 |
Activities of clindamycin, synercid, telithromycin, linezolid, and mupirocin against Gram-positive coccal strains resistant to erythromycin in Korea.
Topics: Acetamides; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Ketolides; Korea; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Virginiamycin | 2007 |
In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
Topics: Anti-Bacterial Agents; Clindamycin; Coagulase; Drug Resistance, Bacterial; Erythromycin; Ketolides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptogramin A; Streptogramin B; Virginiamycin | 2007 |
Characterization of antimicrobial resistance in Enterococcus spp. recovered from a commercial beef processing plant.
Topics: Animals; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Erythromycin; Food Handling; Lincomycin; Meat; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Tetracycline Resistance; Virginiamycin | 2010 |
Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Topics: Anti-Bacterial Agents; Clindamycin; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genes, Bacterial; Genotype; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Streptogramin B; Tertiary Healthcare; Virginiamycin | 2015 |
Mobile elements and chromosomal changes associated with MLS resistance phenotypes of invasive pneumococci recovered in the United States.
Topics: Anti-Bacterial Agents; Chromosomes, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Humans; Interspersed Repetitive Sequences; Lincosamides; Macrolides; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Streptococcus pneumoniae; Streptogramins; United States; Virginiamycin | 2015 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Child, Preschool; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Farmers; Female; Gentamicins; Humans; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Swine; Swine Diseases; Taiwan; Tigecycline; Virginiamycin | 2018 |
In vitro synergistic effect of retapamulin with erythromycin and quinupristin against Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Gram-Positive Bacterial Infections; Humans; Macrolides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pyogenes; Virginiamycin | 2020 |